SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-21-002942
Filing Date
2021-01-20
Accepted
2021-01-19 17:33:26
Documents
25

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO FORM F-1 ea133431-f1a5_nlspharma.htm F-1/A 2082569
2 FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDER ea133431ex1-1_nlspharma.htm EX-1.1 437305
3 AMENDMENT NUMBER 4 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN ea133431ex10-29_nlspharma.htm EX-10.29 17496
4 AMENDMENT NUMBER 2 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M ea133431ex10-30_nlspharma.htm EX-10.30 29512
5 AMENDMENT NUMBER 3 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M ea133431ex10-31_nlspharma.htm EX-10.31 21337
6 FORM OF ADDENDUM NUMBER 4 TO PROMISSORY NOTE DATED JANUARY 2019 BETWEEN CERTAIN ea133431ex10-32_nlspharma.htm EX-10.32 14323
7 ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS PHARMA AG ea133431ex10-33_nlspharma.htm EX-10.33 21929
8 ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS-1 PHARMA ea133431ex10-34_nlspharma.htm EX-10.34 54351
9 ADDENDUM NUMBER 4 TO CONVERTIBLE PROMISSORY NOTE DATED JANUARY 18, 2019 BETWEEN ea133431ex10-35_nlspharma.htm EX-10.35 18127
10 CONSENT OF MARCUM LLP ea133431ex23-1_nlspharma.htm EX-23.1 3160
11 REGISTRANT'S REPRESENTATION PURSUANT TO REQUIREMENTS OF FORM 20-F, ITEM 8.A.4 ea133431ex99-3_nlspharma.htm EX-99.3 10752
12 GRAPHIC image_001.jpg GRAPHIC 14073
13 GRAPHIC image_004a.jpg GRAPHIC 30789
14 GRAPHIC image_005.jpg GRAPHIC 34402
15 GRAPHIC image_006.jpg GRAPHIC 14916
16 GRAPHIC image_007.jpg GRAPHIC 17745
17 GRAPHIC image_008.jpg GRAPHIC 11253
18 GRAPHIC image_009.jpg GRAPHIC 22650
19 GRAPHIC image_010.jpg GRAPHIC 15414
20 GRAPHIC image_011.jpg GRAPHIC 18536
21 GRAPHIC image_012.jpg GRAPHIC 23274
22 GRAPHIC image_013.jpg GRAPHIC 46910
23 GRAPHIC image_014.jpg GRAPHIC 13369
24 GRAPHIC image_015.jpg GRAPHIC 46220
25 GRAPHIC image_016.jpg GRAPHIC 95983
  Complete submission text file 0001213900-21-002942.txt   3272163
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-79-779-60-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236797 | Film No.: 21536592
SIC: 2834 Pharmaceutical Preparations